CARP-1 functional mimetics are a novel class of small molecule inhibitors of malignant pleural mesothelioma cells.
Malignant pleural mesothelioma (MPM) is an asbestos-related thoracic malignancy that is characterized by late metastases, and resistance to therapeutic modalities. The toxic side-effects of MPM therapies often limit their clinical effectiveness, thus necessitating development of new agents to effect...
Guardado en:
Autores principales: | Shazia Jamal, Vino T Cheriyan, Magesh Muthu, Sara Munie, Edi Levi, Abdelkader E Ashour, Harvey I Pass, Anil Wali, Mandip Singh, Arun K Rishi |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f40d635b267c4d139155c3e53e35e55b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Cytomegalovirus infection in malignant pleural mesothelioma.
por: DeVon Hunter-Schlichting, et al.
Publicado: (2021) -
Modern management of malignant pleural mesothelioma
por: Patel SC, et al.
Publicado: (2016) -
Integrated genomics point to immune vulnerabilities in pleural mesothelioma
por: Anca Nastase, et al.
Publicado: (2021) -
Malignant Pleural Mesothelioma Nodal Status: Where Are We at?
por: Sara Ricciardi, et al.
Publicado: (2021) -
Clinical staging of malignant pleural mesothelioma: current perspectives
por: Bonomi M, et al.
Publicado: (2017)